• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 58 of 100
CNBC Events
Health
Botox Maker Allergan’s CEO Defends Selling Drug Patents to Native American Tribe to Thwart Rivals
By Sy MukherjeeSeptember 9, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
Leadership
Prosecutors Want Martin Shkreli Jailed After Hillary Clinton Hair ‘Threat’
By Lucinda ShenSeptember 8, 2017
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health
This Controversial Biotech May Yet Defy Its Skeptics
By Sy MukherjeeSeptember 6, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
Health
Novartis CEO Joseph Jimenez Is Stepping Down
By David MeyerSeptember 4, 2017
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
Health
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
By Sy MukherjeeAugust 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
Health
The Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.
By Sy MukherjeeAugust 30, 2017
Elijah Cummings, Peter Welch
Health
House Democrats Start Multiple Sclerosis Drug Price Probe
By BloombergAugust 17, 2017
Fosun International Ltd. Chairman And Billionaire Guo Guangchang Attends Interim Results News Conference
Finance
China’s Fosun Is Defying Beijing’s Crackdown on Debt and Foreign M&A
By Fortune Editors and ReutersAugust 14, 2017
Forbes Under 30 Summit
Health
Why SoftBank Made a Record-Breaking $1.1 Billion Bet on This Biotech Firm
By Sy MukherjeeAugust 9, 2017
Why Martin Shkreli Won’t Be the Last Pharma Bro
Commentary
Why Martin Shkreli Won’t Be the Last Pharma Bro
By Josh HoxieAugust 8, 2017
Hepatitis C drug can cure, if patients can get it
Health
The FDA Just Approved the First Drug That Can Treat All Hepatitis C Strains in Just 8 Weeks
By Sy MukherjeeAugust 3, 2017
Inside Teva Pharmaceuticals Headquarters
Finance
Pharma Giant Teva’s Stock Is Imploding As Generic Drugs Get Cheaper
By BloombergAugust 3, 2017
Jury Deliberations Continue In Martin Shkreli Securities Fraud Trial
Finance
Jury in Martin Shkreli Trial Asks the Judge to Define ‘Fraudulent Intent’
By ReutersAugust 1, 2017
World Science Festival
Health
What You Should Know About ALS, The Disease That Killed Actor and Playwright Sam Shepard
By Sy MukherjeeJuly 31, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli Case Nears End As Lawyers Prepare For Final Argument
Finance
Jury to Soon Begin Deliberations in ‘Pharma Bro’ Martin Shkreli’s Fraud Trial
By ReutersJuly 28, 2017
1...
  • 56
  • 57
  • 58
  • 59
  • 60
...100
Most Popular
Economy
Bill Gates believes a billionaire's tax is the only option in the age of AI—and 'whatever's left over' can be used as a philanthropic safety netplaceholder alt text
By Eleanor PringleNovember 6, 2026
Politics
Voters in Silicon Valley rejected the billionaire wealth tax while those in Los Angeles and San Francisco—home to the two top AI companies—wanted itplaceholder alt text
By Jason MaNovember 6, 2026
Politics
‘Pick another protein’: A cattle rancher senator’s answer on beef prices could give Democrats their first Mississippi Senate win since 1982placeholder alt text
By Catherina GioinoNovember 6, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.